Related Experiment Video
Updated: Dec 17, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Challenges in the diagnosis of diabetes type in pediatrics
Alejandro F Siller1, Mustafa Tosur1, Shilpi Relan1
1Diabetes and Endocrinology Section, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Insights
Accurate diabetes classification is crucial for children, especially with rising obesity and diverse populations. New approaches are needed to improve diagnosis and treatment for better health outcomes in pediatric diabetes.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Increasing incidence of type 1 and type 2 diabetes in children.
- Worsening health outcomes and disproportionate impact on minority racial/ethnic groups.
- Challenges in accurate diabetes classification due to obesity and demographic shifts.
Purpose of the Study:
- To review current challenges in classifying pediatric diabetes types.
- To discuss the limitations of existing diabetes classification schemes.
- To propose alternative classification approaches for improved pediatric diabetes management.
Main Methods:
- Literature review of current diabetes classification systems.
- Analysis of factors complicating pediatric diabetes diagnosis (obesity, demographics, migration).
- Exploration of proposed alternative classification schemes.
Main Results:
- Current classification schemes show increasing overlap and heterogeneity.
- Obesity and changing demographics significantly complicate accurate diabetes typing in children.
- Existing methods are insufficient for precise classification across diverse pediatric populations.
Conclusions:
- Accurate and timely classification of pediatric diabetes is essential for effective treatment.
- Addressing classification challenges is a critical first step to improving diabetes outcomes.
- Novel classification strategies are needed to enhance diagnostic accuracy and patient care.
Abstract:
The incidence of diabetes, both type 1 and type 2, is increasing. Health outcomes in pediatric diabetes are currently poor, with trends indicating that they are worsening. Minority racial/ethnic groups are disproportionately affected by suboptimal glucose control and have a higher risk of acute and chronic complications of diabetes. Correct clinical management starts with timely and accurate classification of diabetes, but in children this is becoming increasingly challenging due to high prevalence of obesity and shifting demographic composition. The growing obesity epidemic complicates classification by obesity's effects on diabetes. Since the prevalence and clinical characteristics of diabetes vary among racial/ethnic groups, migration between countries leads to changes in the distribution of diabetes types in a certain geographical area, challenging the clinician's ability to classify diabetes. These challenges must be addressed to correctly classify diabetes and establish an appropriate treatment strategy early in the course of disease for all. This may be the first step in improving diabetes outcomes across racial/ethnic groups. This review will discuss the pitfalls in the current diabetes classification scheme that is leading to increasing overlap between diabetes types and heterogeneity within each type. It will also present proposed alternative classification schemes and approaches to understanding diabetes type that may improve the timely and accurate classification of pediatric diabetes type.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

